SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-025289
Filing Date
2024-06-26
Accepted
2024-06-26 16:46:23
Documents
14
Period of Report
2024-06-20
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39599
2 ex3-1.htm EX-3.1 336795
  Complete submission text file 0001493152-24-025289.txt   625763

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE evfm-20240620.xsd EX-101.SCH 3009
4 XBRL LABEL FILE evfm-20240620_lab.xml EX-101.LAB 34916
5 XBRL PRESENTATION FILE evfm-20240620_pre.xml EX-101.PRE 22785
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3857
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36754 | Film No.: 241074232
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)